54 results
8-K
EX-99.1
NKTX
Nkarta Inc
13 Jun 24
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
4:22pm
fellowship in investigative rheumatology/immunobiology at Yale University. He also earned a master’s degree in clinical investigation from Vanderbilt
8-K
EX-1.1
NKTX
Nkarta Inc
28 Mar 24
Other Events
4:08pm
; and no such proceedings are threatened or, to the Company’s knowledge after reasonable investigation and due diligence inquiry (“Knowledge … of any such Regulatory Authorizations; (iv) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation
8-K
EX-99.1
7xn6p
21 Mar 24
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
4:15pm
8-K
EX-99.1
kq8tfxct
9 Nov 23
Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights
4:06pm
8-K
EX-1.1
w4yuo2dollu9p3
28 Apr 22
Other Events
4:20pm
8-K
EX-99.1
nn4 g9ynygvpez1vaspp
25 Apr 22
Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs
7:52am
S-3
EX-1.2
mlaib
12 Aug 21
Shelf registration
5:04pm